CJP

CJP (formerly CJ PARTNERS) is a specialized life sciences consulting and advisory firm headquartered in Tokyo, Japan. Founded in 2012, the company bridges the gap between Western and Eastern therapeutic developers, with a primary focus on Japan's regenerative medicine ecosystem. CJP provides bilingual strategic and regulatory support across four core pillars: market analysis, strategic partnering, regulatory advisory, and clinical operations (including serving as an in-country clinical caretaker and trial secretariat). In April 2026, CJP was acquired by Dark Horse Consulting Group (DHCG) to expand its Asia-Pacific footprint and strengthen its cross-border cell and gene therapy expertise.